International Journal of Pharmaceutical Compounding

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

LEARN MORE

Lisinopril 1 mg/mL in SyrSpend SF pH4

Author(s): Allen Loyd V Jr

Issue: Jul/Aug 2020 - Volume 24, Number 4
View All Articles in Issue

Page(s): 318

Lisinopril 1 mg/mL in SyrSpend SF pH4 Page 1

Download in electronic PDF format for $75

Abstract: A formulation for preparing Lisinopril 1 mg/mL in SyrSpend SF pH4. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: formulation, lisinopril, long-acting angiotensin-converting enzyme inhibitor, ACE inhibitor, antihypertensive agent, hypertension, high blood pressure

Related Categories: FORMULATIONS, CARDIOLOGY

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Lisinopril 1 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Jul/Aug 2020 Pg. 318
Lisinopril 1-mg/mL, Sodium Citrate, and Citric Acid Oral Liquid Allen Loyd V Jr	Sep/Oct 2006 Pg. 386
Lisinopril 1-mg/mL Oral Liquid Allen Loyd V Jr	Jul/Aug 2006 Pg. 302
Enalapril Maleate 1 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Nov/Dec 2018 Pg. 494
Captopril 0.8 mg/mL in SyrSpend SF Oral Suspension Allen Loyd V Jr	Mar/Apr 2019 Pg. 148
Wetting and/or Solubilizing Agents, Featured Excipient: Allen Loyd V Jr	Jul/Aug 2001 Pg. 310-312
Compounding in the Pharmacy Curriculum: Beyond the Basics Hinkle Amanda R, Newton Gail D	May/Jun 2004 Pg. 181-185
Formulation and In Vitro Evaluation of a Ramipril Entrapped in a Microsponge-based Drug-delivery System Taghi Hassanien Sagban, Abdulbaqi Mustafa R, Samein Laith Hamza, Rahmani Maha H Philip	Jul/Aug 2023 Pg. 340-346
Quinapril 1-mg/mL Oral Liquid Allen Loyd V Jr	May/Jun 2006 Pg. 227
Enalapril Maleate 1-mg/mL Oral Suspension Allen Loyd V Jr	May/Jun 2006 Pg. 221
Stability of Captopril in SyrSPend SF Geiger Christine M, Sorenson Bridget, Whaley Paul A	Jul/Aug 2013 Pg. 336-338
Spironolactone 2-mg/mL or 2-5.mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Sep/Oct 2021 Pg. 421
Verapmail Hydrochloride 50 mg/mL in SyrSpend SF Allen Loyd V Jr	Nov/Dec 2019 Pg. 494
Stability of Atenolol, Clonazepam, Dexamethasone, Diclofenac Sodium, Diltiazem, Enalapril Maleate, Ketoprofen, Lamotrigine, Penicillamine-D, and Thiamine in SyrSpend SF PH4 Oral Suspensions Polonini HC, Loures S, Lima LC, Ferreira AO, Brandão MA	Mar/Apr 2016 Pg. 167-174
Benazepril 2-mg/mL Oral Liquid Allen Loyd V Jr	May/Jun 2007 Pg. 242
Basics of Compounding for Cough Allen Loyd V Jr	Nov/Dec 2004 Pg. 462-465
Enalapril Maleate 1 mg-mL in Ora-Plus and Ora-Sweet Suspension Allen Loyd V Jr	Jan/Feb 2022 Pg. 56
Atenolol 1 mg/mL or 5 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	May/Jun 2018 Pg. 233
Tacrolimus Monohydrate 1 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Nov/Dec 2019 Pg. 491
Metoprolol Tartrate 10 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Nov/Dec 2021 Pg. 503
Return to Top